Exelixis, Inc (EXEL) Covered Calls

Exelixis, Inc covered calls Exelixis, Inc. is committed to developing innovative therapies for cancer and other serious diseases.

You can sell covered calls on Exelixis, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for EXEL (prices last updated Fri 3:25 PM ET):

Exelixis, Inc (EXEL) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
22.20 -0.10 22.20 22.21 2.9M 19 6.7B
Covered Calls For Exelixis, Inc (EXEL)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Mar 15 22 1.15 21.06 4.5% 56.6%
May 17 22 2.45 19.76 11.3% 44.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Exelixis, Inc. is a biopharmaceutical company, which engages in the developing and commercializing small molecule therapies for the treatment of cancer. Its two advanced assets are COMETRIQ and cobimetinib. The company focuses on their proprietary resources and development and commercialization of cabozantinib. Exelixis was founded by Corey S. Goodman and Stelios B. Papadopoulos on November 15, 1994 and is headquartered in South San Francisco, CA.